Latest Insider Transactions at Sage Therapeutics, Inc. (SAGE)
This section provides a real-time view of insider transactions for Sage Therapeutics, Inc. (SAGE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sage Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sage Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2024
|
Christopher Benecchi Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+20.17%
|
-
|
|
Nov 01
2024
|
Gregory L. Shiferman |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+20.03%
|
-
|
|
Aug 05
2024
|
Christopher Benecchi Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,755
-20.46%
|
$38,040
$8.96 P/Share
|
|
Aug 05
2024
|
Christopher Benecchi Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,200
+41.07%
|
-
|
|
Aug 05
2024
|
Anne Marie Cook SVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,503
-15.78%
|
$36,024
$8.96 P/Share
|
|
Aug 05
2024
|
Anne Marie Cook SVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+32.11%
|
-
|
|
Aug 05
2024
|
Kimi Iguchi CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,636
-4.28%
|
$29,088
$8.96 P/Share
|
|
Aug 05
2024
|
Kimi Iguchi CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+13.7%
|
-
|
|
Aug 05
2024
|
Laura Gault Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,288
-23.44%
|
$26,304
$8.96 P/Share
|
|
Aug 05
2024
|
Laura Gault Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+49.05%
|
-
|
|
Aug 05
2024
|
Barry E Greene President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,273
-12.61%
|
$98,184
$8.96 P/Share
|
|
Aug 05
2024
|
Barry E Greene President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,400
+34.11%
|
-
|
|
Feb 13
2024
|
Kimi Iguchi CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
11,250
+12.11%
|
-
|
|
Feb 13
2024
|
Christopher Benecchi Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+41.0%
|
-
|
|
Feb 13
2024
|
Laura Gault Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,250
+49.5%
|
-
|
|
Feb 13
2024
|
Anne Marie Cook SVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
11,250
+30.88%
|
-
|
|
Jan 02
2024
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,642
+2.28%
|
$1,642
$1.36 P/Share
|
|
Nov 28
2023
|
Anne Marie Cook SVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,174
-7.88%
|
$22,306
$19.27 P/Share
|
|
Nov 28
2023
|
Anne Marie Cook SVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+21.18%
|
-
|
|
Nov 28
2023
|
Jeffrey M Jonas |
SELL
Payment of exercise price or tax liability
|
Direct |
3,935
-2.98%
|
$74,765
$19.27 P/Share
|
|
Nov 28
2023
|
Jeffrey M Jonas |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+7.04%
|
-
|
|
Nov 28
2023
|
Kimi Iguchi CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
943
-1.35%
|
$17,917
$19.27 P/Share
|
|
Nov 28
2023
|
Kimi Iguchi CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
3,500
+4.78%
|
-
|
|
Aug 09
2023
|
Elizabeth Barrett |
BUY
Open market or private purchase
|
Direct |
2,000
+40.0%
|
$36,000
$18.64 P/Share
|
|
May 09
2023
|
Elizabeth Barrett |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$50,000
$50.5 P/Share
|
|
Mar 15
2023
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+4.38%
|
$3,000
$1.36 P/Share
|
|
Feb 23
2023
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+0.4%
|
$250
$1.36 P/Share
|
|
Feb 21
2023
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+1.19%
|
$750
$1.36 P/Share
|
|
Feb 10
2023
|
Jeffrey M Jonas |
SELL
Open market or private sale
|
Direct |
11,643
-4.45%
|
$512,292
$44.69 P/Share
|
|
Feb 10
2023
|
Jeffrey M Jonas |
BUY
Exercise of conversion of derivative security
|
Direct |
11,643
+8.01%
|
$0
$0.45 P/Share
|
|
Feb 03
2023
|
Christopher Benecchi Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,119
-28.72%
|
$93,236
$44.16 P/Share
|
|
Feb 03
2023
|
Christopher Benecchi Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,750
+47.77%
|
-
|
|
Feb 03
2023
|
Anne Marie Cook SVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
980
-8.54%
|
$43,120
$44.16 P/Share
|
|
Feb 03
2023
|
Anne Marie Cook SVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
2,850
+19.89%
|
-
|
|
Feb 03
2023
|
Kimi Iguchi CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
914
-1.46%
|
$40,216
$44.16 P/Share
|
|
Feb 03
2023
|
Kimi Iguchi CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
2,850
+4.36%
|
-
|
|
Feb 03
2023
|
Albert Robichaud Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,127
-0.77%
|
$49,588
$44.16 P/Share
|
|
Feb 03
2023
|
Albert Robichaud Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,375
+2.25%
|
-
|
|
Feb 03
2023
|
Jeffrey M Jonas |
SELL
Payment of exercise price or tax liability
|
Direct |
1,427
-1.16%
|
$62,788
$44.16 P/Share
|
|
Feb 03
2023
|
Jeffrey M Jonas |
BUY
Grant, award, or other acquisition
|
Direct |
5,100
+3.97%
|
-
|
|
Jan 09
2023
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+2.61%
|
$1,600
$1.36 P/Share
|
|
Jan 04
2023
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,800
+3.01%
|
$1,800
$1.36 P/Share
|
|
Jan 03
2023
|
Jeffrey M Jonas |
BUY
Exercise of conversion of derivative security
|
Direct |
2,501
+2.07%
|
$70,028
$28.63 P/Share
|
|
Nov 28
2022
|
Steven M Paul |
BUY
Other acquisition or disposition
|
Indirect |
5
+0.01%
|
$190
$38.17 P/Share
|
|
Nov 10
2022
|
Barry E Greene President and CEO |
BUY
Open market or private purchase
|
Direct |
14,500
+23.6%
|
$493,000
$34.48 P/Share
|
|
May 05
2022
|
George Golumbeski |
BUY
Open market or private purchase
|
Direct |
8,000
+50.0%
|
$248,000
$31.45 P/Share
|
|
Apr 27
2022
|
Jeffrey M Jonas |
BUY
Exercise of conversion of derivative security
|
Direct |
30,944
+21.09%
|
$0
$0.45 P/Share
|
|
Feb 17
2022
|
Jeffrey M Jonas |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+4.5%
|
$0
$0.45 P/Share
|
|
Feb 17
2022
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+7.49%
|
$4,500
$1.36 P/Share
|
|
Nov 23
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.92%
|
$1,000
$1.36 P/Share
|